The Enhancement Effect of Low-Level Laser Therapy for Muscle Training with Combined NMES and BFR

December 16, 2024 updated by: National Cheng-Kung University Hospital

The Enhancement Effect of Low-Level Laser Therapy for Muscle Training with Combined Neuromuscular Electrical Stimulation and Blood Flow Restriction

Blood flow restriction training (BFR) with neuromuscular stimulation (NMES) is employed for individuals with limited mobility and joint issues. However, this approach is highly susceptible to muscle fatigue, despite its potential beneficial effects on muscle strength. Recently, there has been growing interest in using low-level laser therapy (LLLT) to address muscle fatigue. LLLT, known for improving microcirculation and mitochondrial function, shows promise in alleviating enhanced muscle fatigue associated with combined BFR and NMES training. Despite these positive effects, there is limited knowledge about the short-term training impact of combined BFR and NMES with LLLT preconditioning. This project aims to investigate whether the photobiomodulation effects of LLLT could further enhance the training benefits of combined BFR and NMES. The study will employ an integrated analysis of decomposition surface EMG, EEG, and mechanomyogram to explore the behavior and neuromuscular mechanisms underlying the training benefits. If additional benefits are identified, LLLT pre-conditioning is recommended to enhance the use of combined BFR and NMES.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

44

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Ing-Shiou Hwang, PhD
  • Phone Number: 5024 +886 62353535
  • Email: ensureh@gmail.com

Study Contact Backup

Study Locations

      • Tainan, Taiwan
        • Recruiting
        • National Chen Kong University Hospital, Tainan
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Healthy adults aged 20-40, without a diagnosis of cardiovascular or neuromusculoskeletal diseases.
  2. Normal vision range after visual correction.

Exclusion Criteria:

  1. Exclude students who have a teacher-student relationship with the principal investigator to ensure the participants' autonomy.
  2. History of brain injury, stroke, spinal cord injury, or other neuromuscular-related conditions.
  3. Contraindications for laser therapy: pregnancy, malignant tumor tissues, bleeding areas, and photosensitive skin regions.
  4. Presence of any contraindications for blood flow restriction training, such as a history of injury or strain in the non-dominant arm's biceps, deep vein thrombosis or venous occlusion in the non-dominant arm, acute unstable fractures in the non-dominant arm, acute regional infections in the non-dominant arm, severe peripheral arterial occlusive disease in the non-dominant arm, complete lymphatic obstruction in the non-dominant arm, and edema due to acute pulmonary edema or congestive heart failure in the non-dominant arm.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: LLLT+BFR+NMES

LLLT: low-level laser therapy BFR: blood flow restriction NMES:neuromuscular Electrical Stimulation

35 min/time, 3 times/weeks, 3 weeks

Low-level laser therapy can increase cellular energy production, making it useful as a pre-conditioning treatment to prevent muscle contraction fatigue or as a post-contraction therapy to accelerate fatigue recovery.
Its advantage is that during training, it can surpass the "overload principle," allowing for effective muscle cross-sectional area growth with relatively light weight training (20%-50% of 1RM or 20%-40% of MVC).
It is a strength training method that uses electrical currents to stimulate nerve and muscle activation, helping to maintain muscle mass, increase blood flow, and slow down or prevent muscle atrophy.
Experimental: BFR+NMES

BFR: blood flow restriction NMES:Neuromuscular Electrical Stimulation

35 min/time, 3 times/weeks, 3 weeks

Its advantage is that during training, it can surpass the "overload principle," allowing for effective muscle cross-sectional area growth with relatively light weight training (20%-50% of 1RM or 20%-40% of MVC).
It is a strength training method that uses electrical currents to stimulate nerve and muscle activation, helping to maintain muscle mass, increase blood flow, and slow down or prevent muscle atrophy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Myoton
Time Frame: before training, 1week of training, 2 weeks of training, at the end of 3 weeks training
Non-dominant hand extensor digitorum muscle belly parameters of static mechanical properties of muscles (Tone, Stiffness, Relaxation, Creep, etc.)
before training, 1week of training, 2 weeks of training, at the end of 3 weeks training
Mechanomyogram
Time Frame: before training, 1week of training, 2 weeks of training, at the end of 3 weeks training
Recording of extensor digitorum muscle microshock waves during contraction
before training, 1week of training, 2 weeks of training, at the end of 3 weeks training
Multi-electrode surface EMG
Time Frame: before training, at the end of 3 weeks training
Record muscle activity during contraction
before training, at the end of 3 weeks training
Dynamometer System
Time Frame: before training, 1week of training, 2 weeks of training, at the end of 3 weeks training
Measurement to track the degree of force applied by a non-dominant hand.
before training, 1week of training, 2 weeks of training, at the end of 3 weeks training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Ing-Shiou Hwang, PhD, NCKU, Institute of Allied Health Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Estimated)

July 31, 2025

Study Completion (Estimated)

July 31, 2025

Study Registration Dates

First Submitted

September 12, 2024

First Submitted That Met QC Criteria

December 16, 2024

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

December 16, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Muscle Strength

Clinical Trials on Low Level Laser Therapy

Subscribe